Hatch Closing Act: OTC Monograph Reform Legislation?
This article was originally published in The Pink Sheet & The Rose Sheet
The Utah Republican has been instrumental during his more than 40 years in office in passing legislation central to the growth of the OTC drug and dietary supplement industries. But the expansion of the OTC market is stifled by FDA's monograph system for making more ingredients available, a process agency officials say no longer works.
You may also be interested in...
Dietary supplements would be covered in pre-tax health savings accounts under Senate legislation. Industry groups say the health and economic impact of COVID-19 makes including supplements in the accounts more important.
The House Health subcommittee asks whether allowing manufacturers' periods of US market exclusivity for some approved OTC monograph proposals is needed, or would be fair to consumers.
"If the system is broken … my gosh, does it take 45 years for the FDA to say, 'we need help'?" US Rep. Joe Barton, R-TX, asks at House health subcommittee hearing on proposal to streamline the OTC monograph program and establish a user fee program to support FDA's work.